These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 20960612

  • 1. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Mahajan S, Engel WK.
    Neurology; 2010 Oct 12; 75(15):1397-8; author reply 1398-9. PubMed ID: 20960612
    [No Abstract] [Full Text] [Related]

  • 2. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Mauskop A.
    Neurology; 2010 Oct 12; 75(15):1397; author reply 1398-9. PubMed ID: 20938035
    [No Abstract] [Full Text] [Related]

  • 3. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Rison RA.
    Neurology; 2010 Oct 12; 75(15):1397; author reply 1398-9. PubMed ID: 20960668
    [No Abstract] [Full Text] [Related]

  • 4. Assessment: generic substitution for antiepileptic medication. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 1990 Nov 12; 40(11):1641-3. PubMed ID: 2234417
    [No Abstract] [Full Text] [Related]

  • 5. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology.
    Katzberg HD, Khan AH, So YT.
    Neurology; 2010 Feb 23; 74(8):691-6. PubMed ID: 20177124
    [Abstract] [Full Text] [Related]

  • 6. Muscle cramps and magnesium deficiency: case reports.
    Bilbey DL, Prabhakaran VM.
    Can Fam Physician; 1996 Jul 23; 42():1348-51. PubMed ID: 8754704
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Holloway RG.
    Neurology; 2005 Jan 11; 64(1):172-4; author reply 172-4. PubMed ID: 15642936
    [No Abstract] [Full Text] [Related]

  • 12. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology.
    Mauskop A, Mathew N.
    Neurology; 2009 Apr 14; 72(15):1367; author reply 1367-8. PubMed ID: 19365063
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    LaFrance WC.
    Neurology; 2006 Apr 25; 66(8):1287-8; author reply 1287-8. PubMed ID: 16636265
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
    Panayiotopoulos CP, Benbadis SR, Covanis A, Dulac O, Duncan JS, Eeg-Olofsson O, Ferrie CD, Grünewald RA, Kasteleijn-Nolst Trenité DG, Koutroumanidis M, Martinovic Z, Newton RW, Parker AP, Salas-Puig J, Sander JW, Shorvon S, Watanabe K, Whitehouse WP, Youroukos S.
    Neurology; 2005 Jan 11; 64(1):172-4; author reply 172-4. PubMed ID: 15645539
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 2008 May 06; 70(19):1691-8. PubMed ID: 18458229
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Practice advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Dyck PJ.
    Neurology; 2007 Mar 06; 68(10):796; author reply 796. PubMed ID: 17339597
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.